首页|莫匹罗星高产菌株选育

莫匹罗星高产菌株选育

扫码查看
目的 莫匹罗星高产菌株选育,提高发酵水平.方法 用常压室温等离子体诱变(ARTP)选育技术,对莫匹罗星生产菌种PF16002059进行处理,同时结合抗自身代谢产物压力进行选育,并通过摇瓶发酵对突变株进行筛选.结果 得到1株稳定高产的生产菌株PF22033156,该菌株摇瓶发酵水平达到7062 mg/L,较出发菌株PF16002059提升98%.结论 本研究运用ARTP诱变,结合抗自身代谢产物进行选育,获得新菌株荧光假单胞菌PF22033156(Pseudomonas fluorescens PF22033156),其莫匹罗星发酵效价显著提升,且遗传性状稳定,适用于产业化生产.
Screening of high yield strain of mupirocin
Objective This study aimed to screen for a high-mupirocin-producing strain and improve the fermentation level.Methods The breeding technology of atmospheric room temperature plasma mutation(ARTP)was used to screen the strain PF 16002059,which produced mupirocin.At the same time,the resistance to self-produced metabolites was used as the selection pressure,and the mutants were screened by shake flask fermentation.Results A stable and high-yield production strain PF22033156 was obtained.The shake flask fermentation level of the strain PF22033156 reached 7062 mg/L,which was 98%higher than the original strain PF 16002059.Conclusion ARTP mutagenesis combined with resistance to self-produced metabolites were used to screen for the new strain PF22033156(Pseudomonas fluorescens PF22033156)in this study,which significantly increased the production of mupirocinm,and the genetic character of the mutant strain was stable,which made it suitable for industrial production.

MupirocinPseudomonas fluorescensARTP mutation screeningResistance mutation screening

徐浩、徐美冬、杨小虎、毛亮亮、应灵萍、余贞

展开 >

浙江海正药业股份有限公司浙江省抗真菌药物重点实验室,台州 318000

莫匹罗星 荧光假单胞菌 ARTP诱变选育 抗性突变筛选

2024

中国抗生素杂志
中国医药集团总公司四川抗菌素工业研究所,中国医学科学院医药生物技术研究所

中国抗生素杂志

CSTPCD北大核心
影响因子:1.08
ISSN:1001-8689
年,卷(期):2024.49(1)
  • 1